DD201974A5 - Verfahren zur herstellung von festen arzneizubereitungen enthaltend nifedipin - Google Patents

Verfahren zur herstellung von festen arzneizubereitungen enthaltend nifedipin Download PDF

Info

Publication number
DD201974A5
DD201974A5 DD81232939A DD23293981A DD201974A5 DD 201974 A5 DD201974 A5 DD 201974A5 DD 81232939 A DD81232939 A DD 81232939A DD 23293981 A DD23293981 A DD 23293981A DD 201974 A5 DD201974 A5 DD 201974A5
Authority
DD
German Democratic Republic
Prior art keywords
nifedipine
pharmaceutical preparations
specific surface
surface area
preparations containing
Prior art date
Application number
DD81232939A
Other languages
German (de)
English (en)
Inventor
Ahmed Hegasy
Klaus-Dieter Raemsch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6111496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD201974(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DD201974A5 publication Critical patent/DD201974A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DD81232939A 1980-09-09 1981-09-01 Verfahren zur herstellung von festen arzneizubereitungen enthaltend nifedipin DD201974A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803033919 DE3033919A1 (de) 1980-09-09 1980-09-09 Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD201974A5 true DD201974A5 (de) 1983-08-24

Family

ID=6111496

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81232939A DD201974A5 (de) 1980-09-09 1981-09-01 Verfahren zur herstellung von festen arzneizubereitungen enthaltend nifedipin

Country Status (20)

Country Link
EP (1) EP0047899B2 (fr)
JP (1) JPS5914446B2 (fr)
AR (1) AR226377A1 (fr)
AT (1) ATE5761T1 (fr)
AU (1) AU558331B2 (fr)
CA (1) CA1180277A (fr)
DD (1) DD201974A5 (fr)
DE (2) DE3033919A1 (fr)
DK (1) DK154326C (fr)
FI (1) FI72648B (fr)
GR (1) GR78237B (fr)
HU (1) HU184879B (fr)
IE (1) IE51549B1 (fr)
IL (1) IL63749A (fr)
NO (1) NO157368B (fr)
NZ (1) NZ198285A (fr)
PH (1) PH24097A (fr)
PL (1) PL232951A1 (fr)
PT (1) PT73603B (fr)
ZA (1) ZA816213B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
US4529733A (en) * 1983-04-06 1985-07-16 Merrell Dow Pharmaceuticals Inc. Antihypertensive 3-furoyl-1,4-dihydropyridines
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
CH673947A5 (fr) * 1986-09-23 1990-04-30 Sandoz Ag
JPS6464659A (en) * 1987-09-03 1989-03-10 Kenbi Kogaku Kenkyusho Kk Preparation of safe and effective powder formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
JPH0298550U (fr) * 1989-01-25 1990-08-06
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
DK0800392T3 (da) * 1994-12-29 2002-03-18 Shire Deutschland Gmbh & Co Kg Farmaceutiske præparater med indhold af nifedipin samt fremgangsmåde til fremstilling deraf
JP3220373B2 (ja) 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
KR100321489B1 (ko) 1996-07-08 2002-10-09 에드워드 멘델 컴파니 인코포레이티드 고용량의불용성약물용서방성매트릭스
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
IL143375A0 (en) 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
RU2378272C2 (ru) 2004-07-30 2010-01-10 Торрент Фармасьютикалз Лимитед Небиволол и его фармацевтически приемлемые соли, способ их получения и фармацевтические композиции небиволола
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330727A (en) * 1960-04-19 1967-07-11 Glaxo Lab Ltd Griseofulvin with high specific surface area
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
DE2348334C2 (de) * 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
CA1146866A (fr) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Procede de production d'un compose pharmaceutique a liberation continue sous forme solide

Also Published As

Publication number Publication date
NZ198285A (en) 1984-04-27
PH24097A (en) 1990-03-05
IE51549B1 (en) 1987-01-07
FI812758L (fi) 1982-03-10
DE3161838D1 (en) 1984-02-09
IE812075L (en) 1982-03-09
AU558331B2 (en) 1987-01-29
FI72648B (fi) 1987-03-31
GR78237B (fr) 1984-09-26
IL63749A (en) 1984-06-29
DK154326C (da) 1995-03-13
HU184879B (en) 1984-10-29
DE3033919A1 (de) 1982-04-22
DK154326B (da) 1988-11-07
EP0047899A1 (fr) 1982-03-24
ZA816213B (en) 1982-09-29
NO157368B (no) 1987-11-30
NO812879L (no) 1982-03-10
EP0047899B2 (fr) 1996-02-28
JPS5914446B2 (ja) 1984-04-04
AU7506381A (en) 1982-03-18
CA1180277A (fr) 1985-01-02
AR226377A1 (es) 1982-06-30
EP0047899B1 (fr) 1984-01-04
PT73603B (en) 1982-11-10
DK396381A (da) 1982-03-10
JPS5750913A (en) 1982-03-25
IL63749A0 (en) 1981-12-31
ATE5761T1 (de) 1984-01-15
PT73603A (en) 1981-09-01
PL232951A1 (fr) 1982-10-11

Similar Documents

Publication Publication Date Title
EP0047899B1 (fr) Compositions pharmaceutiques solides contenant de la nifédipine et procédé pour leur préparation
EP0126379B1 (fr) Formulation à deux phases
DE3636123C2 (fr)
DE60118008T2 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE2822882A1 (de) Nifedipine-enthaltende feste praeparatzusammensetzung, verfahren zu ihrer herstellung und ihre verwendung
DE3915347A1 (de) Harzadsorbat und verfahren zu seiner herstellung
DE2224534B2 (de) Pharmazeutisches praeparat mit langsamer wirkstoffabgabe
DE3720757A1 (de) Dhp-manteltablette
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
EP0607775A2 (fr) Utilisation de leflunomid pour inhiber interleukin 1 bêta
EP0607776A2 (fr) Utilisation de leflunomid pour inhiber le facteur alpha de necrose tumorale
DE3212736A1 (de) Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE60103276T2 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
DE3419131A1 (de) Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
EP0531845B1 (fr) Composition pharmaceutique comprenant une modification crystalline spéciale de la 1,4-dihydro-2,6-diméthyl-4-(3-nitrophényl)-3,5-pyridine dicarboxylic acide-(-2-méthoxyéthyl)-isopropyl ester
DD242349A5 (de) Verfahren zur herstellung einer synergistischen kombination von flupirtin und 4-acetamido-phenol
DE60220953T2 (de) Pharmazeutische zusammensetzungen enthaltend eine antihistaminische abschwellende arzneistoffkombination und ein verfahren zur herstellung davon
DE3419130A1 (de) Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung
DE3639073A1 (de) Feste arzneizubereitungen und verfahren zu ihrer herstellung
DE2629200A1 (de) Oral verabfolgbares festes antidepressionsmittel und dessen herstellung
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie
EP0800392B1 (fr) Preparations pharmaceutiques contenant de la nifedipine et procedes permettant de les preparer
DE4023136A1 (de) Neue galenische, orale form zur verbesserung der bioverfuegbarkeit von medikamenten
DE3511236A1 (de) Praeparat mit synergistischer bronchienerweiternder wirkung und verfahren zu dessen herstellung

Legal Events

Date Code Title Description
PV Patent disclaimer (addendum to changes before extension act)